Today, several GLP-1 diabetes medications are indicated for improving blood sugar control in people with Type 2 diabetes (see table above)
Human iPSC models of synucleinopathy exhibit neuronal insulin resistance and dysfunctional insulin signalling, which is associated with inhibition of the neuroprotective Akt pathways, and increased expression of the MAPK-associated p38 and JNK stress pathways
This peptide combination supports: Protein synthesis Collagen production Lipolysis (fat burning) Enhanced immune function Cellular repair and regeneration It's important to note that this therapy doesn't "override" your endocrine systemit works in sync with it, making it safer and more sustainable than traditional hormone therapies
A few of these commenters stated that the OAS CAHPS survey is experiencing declining response rates over time and expressed concern that response rates for both surveys may be affected as patients may experience survey fatigue if they receive both surveys from ASCs
Opioid Use Disorder Outcomes In another study by Wang, Volkow, and colleagues, which included roughly 33,000 individuals with Type 2 diabetes and opioid use disorder, semaglutide was associated with a 42-68% lower risk of opioid overdoses compared to other diabetes medications during the 1-year follow-up period (Wang et al., 2024b)
